Healthcare Insights

Image related to an article about Smith & Nephew

Which way now for the Smith & Nephew share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:SN.

Image related to an article about GSK

GlaxoSmithKline share price hits a new 52 week high

Healthcare

Shares in GlaxoSmithKline (LON:GSK) are currently trading close to a 52 week high, with the share price up by around 0.49% to 1,764p over the past week. On a one-month basis, the GlaxoSmithKline price has risen by 1.33%. For investors...

LON:GSK

Image related to an article about EMIS

Four signs of a competitive moat at EMIS (LON:EMIS)

Healthcare

Given that widespread uncertainty in the economy and the stock market is likely to endure for many months, it pays to know that you're investing in high-quality stocks, rather than speculative ones. This means safe, profitable companie...

LON:EMIS^J23

Image related to an article about Genus

Which way now for the Genus share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:GNS

Image related to an article about Abcam

Which way now for the Abcam share price?

Healthcare

Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from h...

LON:ABC^L22

Image related to an article about Healius

Healius passes these three dividend tests

Healthcare

With tens of billions paid out in dividends across the stock market each year, it's no surprise that investors pay close attention to the payouts from shares like Healius (ASX:HLS). The return 'boost' from cash payouts is a crucial par...

ASX:HLS

Image related to an article about EBOS

Two factors that could move the EBOS (NZE:EBO) share price

Healthcare

The EBOS (NZE:EBO) share price is currently trading at NZD39.5. But given that there is still a lot of uncertainty about the health of the wider economy, the question now is what the future holds for it... To try and predict where the...

NZE:EBO

Image related to an article about CSL

What is the broker consensus view on CSL?

Healthcare

'Buy' and 'sell' recommendations from company analysts often catch the attention of investors - but it's worth remembering that city experts can get things wrong. So rather than relying on just one recommendation, a potentially better...

ASX:CSL

Image related to an article about Vita Life Sciences

Is Vita Life Sciences well placed to resist volatility?

Healthcare

An important question for small-cap investors right now is whether the current geopolitical and economic uncertainty will affect the share prices of companies like Vita Life Sciences. The stock is currently trading at A$1.70, but to pr...

ASX:VLS

Image related to an article about Regis Healthcare

Regis Healthcare share price hits a new 52 week high

Healthcare

Shares in Regis Healthcare (ASX:REG) are currently trading close to a 52 week high, with the share price up by around 3.95% to A$2.37 over the past week. On a one-month basis, the Regis Healthcare price has risen by 11.3%. For investor...

ASX:REG

Image related to an article about Monash IVF

Why quality and momentum are powering Monash IVF (ASX:MVF)

Healthcare

Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...

ASX:MVF

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"